SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-23-000027
Filing Date
2023-05-08
Accepted
2023-05-08 16:07:29
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20230331.htm   iXBRL 10-Q 1240578
2 EX-10.2 a102-directorcompensationa.htm EX-10.2 29740
3 EX-10.3 a103-changeinctrlseverance.htm EX-10.3 123810
4 EX-31.1 lgnd_33123exhibit311.htm EX-31.1 15258
5 EX-31.2 lgnd_33123exhibit312.htm EX-31.2 15528
6 EX-32.1 lgnd_33123exhibit321.htm EX-32.1 11256
12 lgnd-20230331_g1.jpg GRAPHIC 51754
  Complete submission text file 0000886163-23-000027.txt   7157068

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20230331.xsd EX-101.SCH 43927
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20230331_cal.xml EX-101.CAL 88955
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20230331_def.xml EX-101.DEF 243643
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20230331_lab.xml EX-101.LAB 624482
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20230331_pre.xml EX-101.PRE 384146
56 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20230331_htm.xml XML 1175094
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 23897765
SIC: 2834 Pharmaceutical Preparations